Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Pancreatology ; 20(3): 307-317, 2020 Apr.
Article in English | MEDLINE | ID: mdl-32198057

ABSTRACT

BACKGROUND/OBJECTIVES: Severe acute pancreatitis (SAP) has a high mortality rate despite ongoing attempts to improve prognosis through a various therapeutic modalities. This study aimed to delineate etiology-based routes that may guide clinical decisions for the treatment of SAP. METHODS: Using data from a recent retrospective multicenter study in Japan, we analyzed the association between clinical outcomes, mainly in-hospital mortality and pancreatic infection, and various etiologies while considering confounding factors. We performed additional multivariate analyses and built decision tree models. RESULTS: The 1097 participating patients were classified into the following groups by etiology: alcohol (n = 436, 39.7%); cholelithiasis (n = 230, 21.0%); idiopathic (n = 227, 20.7%); and others (n = 204, 18.6%). Mortality at hospital discharge was 8.4%, 12.2%, 16.7%, and 16.2% in the alcohol, cholelithiasis, idiopathic, and others groups, respectively. According to multivariable analysis, early enteral nutrition (EN) was significantly associated with reduced in-hospital mortality only in the cholelithiasis group. However, there was a consistent association between age and the need for mechanical ventilation and increased mortality, regardless of etiology. Our decision tree models presented different contributing factors depending on the etiology and patient background. Interaction analysis showed that EN and the use of prophylactic antibiotics may influence these results differently according to etiology. CONCLUSIONS: No study has yet used comprehensive models to investigate etiology-related prognostic factors for SAP; our results can, therefore, be used as a reference for improving clinical decisions.


Subject(s)
Pancreatitis/etiology , Pancreatitis/mortality , Adult , Age Factors , Aged , Aged, 80 and over , Cholelithiasis/complications , Cholelithiasis/mortality , Enteral Nutrition , Female , Hospital Mortality , Humans , Japan/epidemiology , Male , Middle Aged , Pancreatitis, Alcoholic/mortality , Prognosis , Respiration, Artificial , Retrospective Studies , Treatment Outcome
2.
Transpl Int ; 28(10): 1245-50, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26010984

ABSTRACT

Intravascular lymphoma (IVL) is a rare form of B-cell lymphoma. We encountered a rare case of IVL diagnosed in an explanted liver. A 49-year-old man visited a clinic with high fever. Because of elevated liver function, he was diagnosed with acute liver failure. Deceased donor liver transplantation (LT) was performed 16 days after admission. The post-transplantation course was uneventful until IVL was reported in the explanted liver on postoperative day (POD) 21. Rituximab was administered on POD 27, and rituximab-cyclophosphamide, hydroxydaunorubicin, oncovin, prednisone (R-CHOP) treatment administered on POD 38. The R-CHOP treatment was repeated for eight cycles, and the patient remains free of recurrence 1 year post-transplantation. Although systemic lymphoma is a contraindication to transplantation, our experience indicates that IVL can be successfully treated by the administration of prompt chemotherapy after LT for fulminant hepatitis.


Subject(s)
Blood Vessels/pathology , Liver Failure/etiology , Liver Transplantation , Liver/blood supply , Lymphoma, B-Cell/diagnosis , Neoplasms, Multiple Primary/diagnosis , Postoperative Complications/diagnosis , Acute Disease , Antigens, CD20/analysis , Antigens, Neoplasm/analysis , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Cyclophosphamide/administration & dosage , Doxorubicin/administration & dosage , Gallbladder/blood supply , Hemangioma/complications , Hepatic Encephalopathy/etiology , Humans , Immunosuppressive Agents/therapeutic use , Incidental Findings , Liver/pathology , Liver Failure/surgery , Liver Neoplasms/complications , Lymphoma, B-Cell/complications , Lymphoma, B-Cell/drug therapy , Male , Middle Aged , Neoplasm Invasiveness , Neoplasms, Multiple Primary/drug therapy , Postoperative Complications/drug therapy , Prednisone/administration & dosage , Purpura, Thrombocytopenic, Idiopathic/complications , Purpura, Thrombocytopenic, Idiopathic/drug therapy , Purpura, Thrombocytopenic, Idiopathic/surgery , Respiratory Tract Infections/complications , Rituximab/administration & dosage , Splenectomy , Transplants/pathology , Vincristine/administration & dosage
3.
J Intensive Care ; 2(1): 7, 2014.
Article in English | MEDLINE | ID: mdl-25520824

ABSTRACT

During mechanical ventilation, endotracheal tube cuff pressure should be maintained within proper range. We investigated the effect of frequent adjustment on cuff pressure in 27 mechanically ventilated patients. Cuff pressure was recorded every 2 h and was adjusted to 24 cmH2O each time. We found that cuff pressure was decreased by 4.9 ± 2.9 cmH2O from the target value. Cuff pressure decreased to less than 20 cmH2O in 45% of measurement occasions 2 h after adjusting it to 24 cmH2O.

4.
J Anesth ; 20(3): 159-65, 2006.
Article in English | MEDLINE | ID: mdl-16897233

ABSTRACT

PURPOSE: The alveolar epithelial cell type II (AEC-II) is itself able to amplify lung inflammation by producing inflammatory cytokines and chemokines, leading to the activation and recruitment of phagocytes. Sivelestat, a new neutrophil elastase inhibitor, has been shown to attenuate acute lung injury in animal experiments. In the current study, we assessed the effects of sivelestat on the production of chemokines from cultured A549 cells, a human AEC-II-like cell line. METHODS: A549 cells were stimulated with endotoxin or tumor necrosis factor-alpha in the presence of sivelestat (1-100 microg x ml(-1)). Culture supernatant levels of interleukin-8 (IL-8) and monocyte chemoattractant protein-1 (MCP-1) were determined by enzyme-linked immunosorbent assay. The expression of IL-8 and MCP-1 mRNAs in stimulated A549 cells in the presence of sivelestat (100 microg x ml(-1)) was quantified by real-time polymerase chain reaction. RESULTS: Sivelestat, at 100 microg x ml(-1) reduced the accumulation of IL-8 and MCP-1 in the culture medium. The high dose of sivelestat significantly inhibited the expression of IL-8 mRNA in A549 cells. The drug also decreased MCP-1 mRNA expression, although not significantly. CONCLUSION: These data suggest that a high dose of sivelestat regulates the production of IL-8 and MCP-1 in AEC-II.


Subject(s)
Chemokine CCL2/biosynthesis , Epithelial Cells/drug effects , Glycine/analogs & derivatives , Interleukin-8/biosynthesis , Pulmonary Alveoli/drug effects , Serine Proteinase Inhibitors/pharmacology , Sulfonamides/pharmacology , Cells, Cultured/drug effects , Cells, Cultured/immunology , Cells, Cultured/metabolism , Chemokine CCL2/drug effects , Chemokine CCL2/immunology , Dose-Response Relationship, Drug , Endotoxins/administration & dosage , Enzyme-Linked Immunosorbent Assay , Epithelial Cells/immunology , Epithelial Cells/metabolism , Glycine/pharmacology , Humans , In Vitro Techniques , Interleukin-8/immunology , Polymerase Chain Reaction/methods , Pulmonary Alveoli/immunology , Pulmonary Alveoli/metabolism , RNA, Messenger/immunology , Respiratory Mucosa/drug effects , Respiratory Mucosa/immunology , Time Factors , Tumor Necrosis Factor-alpha/administration & dosage
5.
Masui ; 52(12): 1300-4, 2003 Dec.
Article in Japanese | MEDLINE | ID: mdl-14733080

ABSTRACT

Pulmonary thromboembolism (PTE) is a crucial complication characterized by rapid onset and a high mortality rate. There are few reports concerning perioperative incidence of PTE and deep vein thrombosis (DVT) among Japanese population. All surgical patients excluding young patients for minor surgery were equipped with calf- or thigh-length intermittent pneumatic compression (IPC) device as a DVT preventive method during the period of immobility. Incidence and clinical characteristics of perioperative PTE and DVT under the use of IPC device were analyzed at Kobe University Hospital. One patient developed DVT and four patients developed PTE among the 6500 surgical cases. All patients with DVT or PTE were 66 years or older, and all patients were diagnosed by computer tomography, venography and pulmonary angiography between 7 to 14 days after each operation. One patient was surgically treated by embolectomy and removal of intraarterial thrombus, and others were treated with thrombolysis, anticoagulants and placement of vena cava filters. For prevention of DVT and PTE, other preventive methods such as anticoagulants and prolonged application of IPC should be necessary.


Subject(s)
Gravity Suits , Intraoperative Complications/prevention & control , Postoperative Complications/prevention & control , Pulmonary Embolism/prevention & control , Age Factors , Aged , Female , Humans , Incidence , Intraoperative Complications/epidemiology , Male , Postoperative Complications/epidemiology , Pulmonary Embolism/epidemiology , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...